-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
اختيار ملك وموكس نيتيروي للكرنفال 2027 في باريتو
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
NHS to test blood screening designed to detect 13 cancers earlier
-
Worcestershire road closures announced for Remembrance Sunday events
-
Democrats near House takeover as voters judge Trump presidency
-
UBC professor describes police call after Galloway remark as act of care
-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
Trump Prepares Veto Strategy Amid Congressional Shift
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
-
Byron Donalds Elected Florida Governor, Becoming First Black Republican in Role
-
Byron Donalds wins Florida governor race and underscores Republican strength
-
James Talarico defeats Ken Paxton in historic Texas Senate result
-
Commentator predicts possible US strike on Iran as regional tensions rise
-
Goa plans relationship-readiness course amid concern over divorces
-
مستثمرون ومنظمات دولية يطالبون باتفاق عالمي لوقف تطوير الأسلحة ذاتية التشغيل
-
Manchester United climbs standings after 3-2 Champions League win over Roma
-
الهند تطبق هيكل تأمين المركبات الرباعي في ديسمبر المقبل
-
India introduces four-layer motor insurance choice from December 15
-
دمج القطاع الصحي الألماني في استراتيجية الدفاع الشامل
-
Mutual fund returns show shifting leaders across market-cap categories
-
BHEL wins Adani Power projects valued at up to ₹28,000 crore
-
تفاصيل بيع تذاكر نهائي كأس رابطة الأندية البيروفية بين كريستال وعلينزا أتلتيكو
-
IndiGo holds talks with Embraer over potential order for 100 aircraft
-
إيلون ماسك يسخر من هزيمة الجمهوريين بعد إنفاقه مئات الملايين
-
India seeks threefold increase in coal stocks to prevent summer power shortages
-
Indian companies report mixed second-quarter results on November 4
-
Indus Towers expands solar-powered network to 50,000 telecom sites
-
KKR secures Indian regulator approval for Gentari Renewables investment
-
Equitas Small Finance Bank rebounds after naming interim chief executive
-
Bharti Airtel revenue expected to grow at double-digit pace in second quarter
-
اعتقال مواطن ألباني في إيطاليا لانتهاكه حظر الترحيل
-
Titan quarterly profit seen rising as jewellery business drives growth
-
Indian crude-sensitive shares gain after 13% oil-price decline
-
Kuwait finance minister holds economic cooperation talks at COMCEC
-
رينو 5 الكهربائية: اختبار مدى 1000 كيلومتر من نيس إلى باريس
-
Stocks and dollar fall as Democratic election gains reshape markets
-
Abdul El-Sayed declares victory in Michigan Senate contest
-
Kuwait marks key events and anniversaries from national history
-
Democrats capture US Congress in sweeping midterm victory
-
Trump congratulates Democrats and signals willingness to cooperate
-
Manchester United rallies past Roma as PSG dominates in Champions League
-
ترامب يهنئ الديمقراطيين بعد هزيمة الجمهوريين في انتخابات التجديد النصفي
Publicis settles opioid case with US states for $350 mn
Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday.
Publicis Health, part of the French advertising giant Publicis, worked with Purdue Pharma between 2010 and 2019 on marketing material to promote OxyContin and other drugs, New York Attorney General Letitia James said in a press release.
She said the agreement was the first with an advertising agency for its role in the opioid epidemic.
"For a decade, Publicis helped opioid manufacturers like Purdue Pharma convince doctors to overprescribe opioids, directly fueling the opioid crisis and causing the devastation of communities nationwide," James said.
Publicis said in a statement the settlement "is in no way an admission of wrongdoing or liability."
Publicis Health created pamphlets and brochures promoting OxyContin as "safe and unable to be abused," said the New York press release.
Other "aggressive" marketing efforts included working with McKinsey consultants on a program to target doctors who prescribed the most OxyContin with calls touting the drug, according to James.
The settlement distributes funds nationally, with New York garnering $19.2 million of the total, James said.
Publicis described the opioid work as originating with Rosetta, a digital marketing firm the French company acquired in 2011 and shut down 10 years ago.
Rosetta's work on opioids employed tools and language "expressly" approved by US health officials, Publicis said.
It involved communications with health care providers, not patients, the company said.
"Rosetta's role was limited to performing many of the standard advertising services that agencies provide to their clients, for products that are to this day prescribed to patients, covered by major private insurers, Medicare, and authorized by State Pharmacy Boards," Publicis said.
"We recognize the broader context in which that lawful work took place. The fight against the opioid crisis in the United States requires collaboration," the company said.
"We are committed to playing our part. That is why we worked to reach this agreement, and why we are also reaffirming our long-standing decision to turn down any future opioid-related projects."
Of the $350 million in the settlement, $343 million will go for payments to US states and territories and $7 million for legal feels, Publicis said.
Since 1999, more than 800,000 people have died from an overdose involving any opioid, including prescription and illicit opioids, according to the Centers for Disease Control and Prevention.
Y.Shaath--SF-PST